Elizabeth M. Jaffee
Member of Scientific Advisory BoardDr. Elizabeth M. Jaffee is Member of Advisory Council of American Association For Cancer Research. Dr. Jaffee is Scientific Advisory Board of Neuvogen, Inc. She serves as a Member of Scientific Advisory Board at Surge Therapeutics Inc. Dr. Jaffee is Member of Research Advisory Board of Candel Therapeutics, Inc. from March 2025. Dr. Jaffee has been a Member of Research Advisory Board at Candel Therapeutics, Inc. since April 2021. She served as Member of Scientific Advisory Board at NextCure, Inc. from October 2021 until 2022. She serves as Member of Scientific Advisory Board at Achilles Therapeutics plc since May 2020 and served as Member of Scientific Advisory Board at Dragonfly Therapeutics, Inc. until November 2025. She had been Member of Scientific Advisory Board at CStone Pharmaceuticals since March 2019 until 2022. She serves as Deputy Director, Sidney Kimmel Cancer Center at Johns Hopkins University She is Albert "Cubby" Broccoli Professor of Oncology and Director, Cancer Convergence Institute at Johns Hopkins University. She serves as Co-Director at the Skip Viragh Center for Pancreas Cancer, she is an internationally recognized expert in cancer immunology and pancreatic cancer and serves as the Deputy Director of the Sidney Kimmel Comprehensive Cancer Center, Deputy Director of the Institute of Clinical and Translational Research and professor of oncology at Johns Hopkins School of Medicine. She has held a string of leadership positions, including the President of the Board of Directors of the American Association for Cancer Research (AACR) and co-Chair of the former Blue Ribbon Panel for Vice President Joe Biden's National Cancer Moonshot Initiative. Her research focuses on cancer immune therapies including novel immune checkpoint inhibitors and cancer vaccines to overcome immune tolerance to cancers. She is the Chair of the National Cancer Advisory Board for the National Cancer Institute (NCI) which she has been a Member since 2013 and co-Chair of the NCI "Blue Ribbon Panel" for the National Cancer Moonshot Initiative. She was recently elected to the National Academy of Medicine. She serves as Member of Scientific Advisory Board at Genocea Biosciences, Inc. She serves on the Board of Directors for the American Society of Clinical Oncology (ASCO). Dr. Jaffee has extensive experience in the development of cancer immunotherapies, having made important contributions in both the lab and the clinic. She is a member of the Parker Institute for Cancer Immunotherapy and the Cancer Research Institute’s Scientific Advisory Council. She graduated magna cum laude from Brandeis University and received her medical degree from New York Medical College. She completed her residency at the Presbyterian-University Hospital in Pittsburgh, Pennsylvania followed by research fellow position at the University of Pittsburgh.
Positions
- Company NameGenocea Biosciences, Inc.Stock CodeGNCAQPositionMember of Scientific Advisory Board
